Medical Sciences Stack Exchange is a question and answer site for professionals in medical and allied health fields, students of those professions, related academics, and others with a sound understanding of medicine and healthcare-related sciences. It only takes a minute to sign up.
Sign up to join this community
Are there ~simple means to reduce risk of GI (gastro-intestinal) bleeding associated with NSAIDs (non-steroidal anti-inflammatory drugs)(ie aspirin) - besides the common-sense answers?:
By 'simple means', I mean: specific foods, supplements, or over-the-counter drugs that make a difference?
There is convincing evidence that measures, like crushing the tablets before use, taking them with food or water, lower doses and temporary discontinuation of use, are associated with the lower risk of gastrointestinal bleeding.
DISCLAIMER: This information is not intended to interfere with any drug regime prescribed by a doctor.
According to Best Practice & Research: Clinical Gastroenterology, 2000:
NSAIDs can cause damage to the gastroduodenal mucosa via several mechanisms, including the topical irritant effect of these drugs on the epithelium, impairment of the barrier properties of the mucosa, suppression of gastric prostaglandin synthesis, reduction of gastric mucosal blood flow and interference with the repair of superficial injury.
1) Chewing the tablet and taking it with food or water:
Don't swallow the aspirin pill; chew it, and then swallow it with a glass of water. Doing it that way gets the aspirin into your system rapidly, which is what you want. (Harvard Medical School)
Chewing will break the tablet, making it to go through the stomach faster thus decreasing its erosive effect. Water will stimulate gastric emptying thus reducing the contact time of aspirin with gastric mucosa. Note, that milk or fruit juice will slow down gastric emptying. You can still take aspirin with food or with food and water. Food will slow gastric emptying of aspirin, but will dilute it. I don't know which is better, food or water, but both make sense.
2) Smaller doses of NSAIDs will be likely less erosive that the greater ones.
New formulations of NSAIDs may reduce risks of adverse events by using lower doses while providing effective analgesia.
Lower-dose capsules that contain finely milled, rapidly absorbed NSAID particles may also provide analgesia at lower systemic doses. (Drug, Healthcare and Patient Safety, 2015)
3) Topical NSAIDs reduce the risk of side effects:
Topical NSAIDs provided good levels of pain relief in acute conditions such as sprains, strains and overuse injuries, probably similar to that provided by oral NSAIDs. Gel formulations of diclofenac (as Emugel®), ibuprofen, and ketoprofen, and some diclofenac patches, provided the best effects. Adverse events were usually minimal. (Cochrane, 2015)
4) Temporary discontinuation of NSAIDs reduces the risk of GI bleeding:
All types and formulations of NSAIDs appear to increase the risk of UGIBs [upper gastrointestinal bleedings] but the effect appear not to be cumulative and diminish rapidly with discontinue of use. (British Journal of Clinical Pharmacology, 2002)
5) Vitamin C
Ascorbic acid supplementation has been associated with a decreased incidence of bleeding from peptic ulcer disease and with a reduction in NSAID-associated gastric mucosal damage. (Digestive Diseases and Sciences)
Aspirin + vitamin C tablets exist.
6 Foods to AVOID
7) Some NSAIDs are less often associated with GI bleeding than others:
According to the systematic review of studies Individual NSAIDs and Upper Gastrointestinal Complications (Drugs Safety, 2012), NSAIDs with the lowest risk of GI bleeding are aceclofenac, celecoxib and ibuprofen, and the ones with the highest risk are piroxicam, ketorolac and azapropazone (Fig. 2).
Using OTC drugs, such as sucralfate and antacides, sounds promising but was disappointing in reducing the risk of GI bleeding:
Despite promising results with sucralfate in smaller studies [30] or for short-term prophylaxis [26, 31], a randomized, controlled trial conduced by Agrawal and coworkers failed to show a significant benefit of sucralfate in the prevention of gastric ulcers in contrast to misoprostol [32].
Data concerning antacids in the prevention of NSAID-related gastric mucosal injury are scarce, and also disappointing. Especially for long-term prophylaxis no clinical effect was observed with low-dose antacids [26]. (British Journal of Clinical Pharmacology, 2002)
Speaking from my humble experience, when prescribing NSAIDs (especially long-term, e.g. Aspirin as thrombosis prophylaxis) it is standard to combine those with PPIs (Proton Pump Inhibitors) as preventive medication against NSAID-associated GI-events. Clinical trials of this therapy generally show positive outcomes (you can find different articles on this subject, such as http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891010/) which, of course, can be subject to discussion.
